858 Therapeutics Stock
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Sign up today and learn more about 858 Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About 858 Therapeutics Stock
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. The company was founded in 2019 and is headquartered in San Diego, California, USA.
Funding History
March 2020 | $20.1M |
---|---|
September 2021 | $60.0M |
Management
CEO and Founder
Jeffrey Stafford
Board Member
Ali Behbahani
Chief Scientific Officer
Jim Veal
Board Member
Clare Ozawa
VP of Biology
Gretchen Bain
Press
patents - Apr, 13 2024
6,6-fused heterocyclic compounds as mettl3 inhibitorspatents - Apr, 13 2024
3-(6-pyridin-3-yl)-2-[4-(4-methyl-4h-1,2,4-triazol-3-yl)piperidin-1-yl] …patents - Apr, 13 2024
Inhibitors of pargpatents - Apr, 13 2024
Inhibitors of pargbusinesswire - Apr, 6 2024
858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting